BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18577686)

  • 1. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
    Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
    Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
    Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
    Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
    Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
    Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
    Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G
    J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel
    Xie X; Tu J; You H; Hu B
    Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.
    Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H
    Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
    Yang CH; Yue J; Sims M; Pfeffer LM
    PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-Acetoxyjolkinolide B irreversibly inhibits IkappaB kinase and induces apoptosis of tumor cells.
    Yan SS; Li Y; Wang Y; Shen SS; Gu Y; Wang HB; Qin GW; Yu Q
    Mol Cancer Ther; 2008 Jun; 7(6):1523-32. PubMed ID: 18566223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer.
    Wu J; Wu S; Shi L; Zhang S; Ren J; Yao S; Yun D; Huang L; Wang J; Li W; Wu X; Qiu P; Liang G
    Eur J Med Chem; 2017 Jan; 125():1321-1331. PubMed ID: 27886548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
    Xia Y; Weng B; Wang Z; Kang Y; Shi L; Huang G; Ying S; Du X; Chen Q; Jin R; Wu J; Liang G
    Tumour Biol; 2016 Apr; 37(4):4791-801. PubMed ID: 26520440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.
    Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P
    Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
    Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
    PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
    Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
    Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression.
    Aravindan S; Natarajan M; Awasthi V; Herman TS; Aravindan N
    PLoS One; 2013; 8(8):e72464. PubMed ID: 23967300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
    Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.
    Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G
    Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of angular naphthopyrones from the Philippine echinoderm Comanthus species as inhibitors of the NF-κB signaling pathway.
    Chovolou Y; Ebada SS; Wätjen W; Proksch P
    Eur J Pharmacol; 2011 Apr; 657(1-3):26-34. PubMed ID: 21296074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
    Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
    Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
    Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
    BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.